Finance

Lists
4594:TYO
BrightPath Biotherapeutics Co Ltd
Â¥57.00
-3.39%
(-2.00) 1D
Sep 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4594...
Open
Â¥58
High
Â¥59
Low
Â¥56
Mkt. cap
7.92B
Avg. vol.
1.40M
Volume
626.70K
52-wk high
Â¥96
52-wk low
Â¥43
EPS
-Â¥13
Shares outstanding
41.98M
No. of employees
23
Open
Â¥58
High
Â¥59
Low
Â¥56
Mkt. cap
7.92B
Avg. vol.
1.40M
Volume
626.70K
52-wk high
Â¥96
52-wk low
Â¥43
EPS
-Â¥13
Shares outstanding
41.98M
No. of employees
23
About BrightPath Biotherapeutics Co Ltd
CEO-
Employees23
FoundedMay 8, 2003
Headquarters-
SectorBiotechnology
Websitebrightpathbio.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
16.50K
16.50K
-
51.00K
Cost of goods sold
4.00K
4.00K
-
21.00K
Cost of revenue
4.00K
4.00K
-
21.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
232.30M
232.30M
492.02M
338.44M
Operating expense
232.30M
232.30M
492.02M
338.44M
Total operating expenses
232.30M
232.30M
492.02M
338.46M
Operating income
-232.29M
-232.29M
-492.02M
-338.41M
Other non operating income
2.39M
2.39M
4.27M
-18.95M
EBT including unusual items
-230.76M
-230.76M
-491.75M
-349.25M
EBT excluding unusual items
-230.47M
-230.47M
-491.75M
-358.87M
Income tax expense
605.00K
605.00K
605.00K
605.00K
Effective tax rate
-0.26%
-0.26%
-0.12%
-0.17%
Other operating expenses
-
-
-
-
Net income
-231.37M
-231.37M
-492.36M
-349.86M
Net profit margin
-1,402,233.33%
-1,402,233.33%
-
-685,998.04%
Earnings per share
-
-
-
-
Interest and investment income
6.00K
6.00K
-
4.00K
Interest expense
-
-
-
-
Net interest expenses
6.00K
6.00K
-
4.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps